Carbubarb
![]() | |
| Clinical data | |
|---|---|
| Trade names | Nogexan |
| ATC code | none |
| Identifiers | |
| |
| Synonyms | Carbubarbital |
| CAS Number |
960-05-4 |
| PubChem (CID) | 13743 |
| ChemSpider |
13148 |
| UNII |
SIW4YR11ST |
| ChEMBL |
CHEMBL2104020 |
| Chemical and physical data | |
| Formula | C11H17N3O5 |
| Molar mass | 271.270 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Carbubarb (Carbubarbital, trade name Nogexan) is a carbamate-substituted barbiturate derivative, which has sedative effects.[1]
References
- ↑ US patent 4428887, Tou, J. S. & Schleppnik, A. A., "Method of producing mono-substituted terminal diesters", issued 1984-01-31, assigned to Monsanto
| Alcohols | |
|---|---|
| Barbiturates |
|
| Benzodiazepines |
|
| Carbamates | |
| Flavonoids | |
| Imidazoles | |
| Kava constituents |
|
| Monoureides |
|
| Neuroactive steroids |
|
| Nonbenzodiazepines |
|
| Phenols | |
| Piperidinediones | |
| Pyrazolopyridines | |
| Quinazolinones | |
| Volatiles/gases |
|
| Others/unsorted |
|
See also: GABAergics | |
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
